Human B cell precursors proliferate and express CD23 after CD40 ligation

Journal of Experimental Medicine

Volumn 178, Issue 1, 1993, Pages 113-120

  Saeland, Sem ^a   Duvert, Valérie ^a   Moreau, Isabelle ^a   Banchereau, Jacques ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CROSS LINKING; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOPOIESIS; PRIORITY JOURNAL; STEM CELL;

ANIMAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HEMATOPOIETIC STEM CELLS; HUMAN; INTERLEUKIN-3; LYMPHOCYTE ACTIVATION; MICE; NEPRILYSIN; PREGNANCY; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE;

EID: 0027301117     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.1.113     Document Type: Article

References (50)

1. Uckun, F.M. 1990. Regulation of human B-cell ontogeny. Blood. 76:1908.
2. Rolink, A., and F. Melchers. 1991. Molecular and cellular origins of B lymphocyte diversity. Cell. 66:1081.
3. Banchereau, J., and F. Rousset. 1992. Human B lymphocytes: phenotype, proliferation and differentiation. Adv. Immunol. 52:125.
4. Clark, E.A., and P.J.L. Lane. 1991. Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 9:97.
5. Stamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lympho-cyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol. Organ.) J. 8:1403.
6. Mallett, S., and A.N. Barclay. 1991. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today. 12:220.
7. Banchereau, J., P. de Paoli, A. Vallé, E. Garcia, and F. Rousset. 1991. Long term human B cell lines dependent on interleukin 4 and anti-CD40. Science (Wash. DC). 251:70.
8. Banchereau, J., and F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature (Lond.). 353:678.
9. Rousset, F., E. Garcia, T. Defrance, C. Péronne, N. Vezzio, D.H. Hsu, R. Kastelein, K.W. Moore, andj. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl. Acad. Sci. USA. 89:1890.
10. Jabara, H.H., D.J. Ahern, D. Vercelli, and R.S. Geha. 1991. Hydrocortisone and IL4 induce IgE isotype switching in human B cells. J. Immunol. 147:1557.
11. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp Med. 173:705.
12. Zhang, X., C. Wemer-Favre, H. Tang, N. Brouwers, J.-Y. Bonnefoy, and R.H. Zubler. 1991. IL-4-dependent IgE switch in membrane IgA-positive human B cells. J. Immunol. 147:3001.
13. + T cell clones and IL-4 induced IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8.
14. Defrance, T., B. Vanbervliet, F. Brière, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor j3 cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp Med. 175:671.
15. Fanslow, W.C., D.M. Anderson, K.H. Grabstein, E.A. Clark, D. Cosman, and R.J. Armitage. 1992. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:655.
16. Graf, D., U. Korthâuer, H.W. Mages, G. Senger, and R.A. Kroczek. 1992. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22:3191.
17. Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573.
18. Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Eur. J. Immunol. 89:6550.
19. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, S. Braesch-Andersen, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO (Eur. Mol. Biol. Organ.)J. 11:4313.
20. Hermann, P., D. Blanchard, B. de Saint-Vis, F. Fossiez, C. Gaillard, B. Vanbervliet, F. Brière, J. Banchereau, and J.-P. Galizzi. 1993. Expression of a 32-kD ligand for the CD40 antigen on activated human T lymphocytes. Eur. J. Immunol. 23:961.
21. Law, C.L., B. Wôrmann, and T.W. LeBien. 1990. Analysis of expression and function of CD40 on normal and leukemic B cell precursors. Leukemia. 4:732.
22. Uckun, F.M., K. Gajil-Peczalska, D.E. Myers, W. Jaszcz, S. Haissig, and J.A. Ledbetter. 1990. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin’s lymphoma cells. Blood. 76:2449.
23. + hematopoietic cells. Exp Hematol. (Charlottesville). 20:24.
24. Uckun, F.M., G.L. Schieven, I. Dibirdik, M. Chandan-Langlie, L. Tuel-Ahlgren, and J.A. Ledbetter. 1991. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 266:17478.
25. Saeland, S., V. Duvert, D. Pandrau, C. Caux, I. Durand, N. Wrighton, J. Wideman, F. Lee, and J. Banchereau. 1991. Interleukin-7 induces the proliferation of normal human B-cell precursors. Blood. 78:2229.
26. dim cells. Blood. 81:1170.
27. Vallé, A., C.E. Zuber, T. Defrance, O. Djossou, M. De Rie, and j. Banchereau. 1989. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19:1463.
28. Bonnefoy, J.Y., J.P. Aubry, C. Péronne, J. Wijdenes, and J. Banchereau. 1987. Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD23 is a low affinity receptor for IgE. J. Immunol. 138:2970.
29. Wolf, M.L., J.A. Buckley, A. Goldfarb, C.-L. Law, and T.W. LeBien. 1991. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J. Immunol. 147:3324.
30. Pandrau, D., S. Saeland, V. Duvert, I. Durand, A.M. Manel, M.T. Zabot, N. Philippe, and j. Banchereau. 1992. Interleukin-4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J. Clin. Invest. 90:1697.
31. Park, Y.-H., and D.G. Osmond. 1989. Dynamics of early B lymphocyte precursor cells in mouse bone marrow: proliferation of cells containing terminal deoxynucleotidyl transferase. Eur. J. Immunol. 19:2139.
32. Wôrmann, B., T.G. Gesner, R.A. Mufson, and T.W. LeBien. 1989. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia. (Basingstoke). 3:399.
33. Delespesse, G., U. Suter, D. Mossalayi, B. Bettler, M. Sarfati, H. Hofstetter, E. Kilcherr, P. Debré, and A. Dalloul. 1991. Expression, structure, and function of the CD23 antigen. Adv. Immunol. 49:149.
34. Kikutani, H., M. Suemura, H. Owaki, H. Nakamura, R. Sato, K. Yamasaki, E.L. Barsumian, R.R. Hardy, and T. Kishimoto. 1986. Fee receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J. Exp. Med. 164:1455.
35. Law, C.-L., R.J. Armitage, J.G. Villablanca, and T.W. LeBien. 1991. Expression of interleukin-4 receptors on early human B-lineage cells. Blood. 78:703.
36. Lederman, S., M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T ceil-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817.
37. Defrance, T., J.P. Aubry, F. Rousset, B. Vanbervliet, J.Y. Bonnefoy, N. Arai, Y. Takebe, T. Yokota, F. Lee, K. Arai, et al. 1987. Human recombinant interleukin 4 induces Fee receptors (CD23) on normal human B lymphocytes. J. Exp Med. 165:1459.
38. + T cell clones. J. Immunol. 141:849.
39. Piccinni, M.P., D. Macchia, P. Parronchi, M.G. Giudizi, D. Bani, R. Alterini, A. Grossi, M. Ricci, E. Maggi, and S. Romagnani. 1991. Human bone marrow non-B, non-T cells produce IL-4 in response to cross-linkage of Fee and Fey receptors. Proc. Natl. Acad. Sci. USA. 88:8656.
40. Letellier, M., T. Nakajima, G. Pulido-Cejudo, H. Hofstetter, and G. Delespesse. 1990. Mechanism of formation of human IgE-binding factors (soluble CD23). III. Evidence for a receptor (FceRII)-associated proteolytic activity. J. Exp Med. 172:693.
41. Mossalayi, M.D., M. Arock, J.M. Bertho, C. Blanc, A.H. Dalloul, H. Hofstetter, M. Sarfati, G. Delespesse, and P. Debré. 1990. Proliferation or early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 75:1924.
42. Mossalayi, M.D., J.C. Lecron, A.H. Dalloul, M. Sarfati, J.M. Bertho, H. Hofstetter, G. Delespesse, and P. Debré. 1990. Soluble CD23 (FceRII) and interleukin 1 synergistically induce early human thymocyte maturation. J. Exp Med 171:959.
43. + murine B-cell progenitors and functions to regulate stromal cell-dependent lymphopoiesis. Blood. 80:2021.
44. Aubry, J.P., S. Pochon, P. Graber, K.U. Jansen, and J.Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature (Lond). 358:505.
45. Galy, A.H., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149:775.
46. Korthauer, U., D. Graf, H.W. Mages, F. Briére, M. Padayachee, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539.
47. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:541.
48. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291.
49. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990.
50. Howard, M.C., A.W. Heath, H. Ishida, and K.W. Moore. 1992. Biological roles of IL-10 and the CD40 receptor. In Progress in Immunology. J. Gergely, editor. Springer-Verlag. Budapest. 327.